CEPACOL

Registered
Word Mark

Key Information

Serial Number

Registration Number

Status

Registered

Ownership

RH

Owner Name

Type: Organization / Limited Liability Company

Address

399 Interpace Parkway
Parsippany, NJ 07054

Critical Dates

First Use Date

Jan 1, 2011

Filing Date

Aug 2, 2023

Registration Date

Jun 24, 2025

Mark Descriptions

Goods

Class 5
Medicated mouthwash in liquid form

Mark Elements

Text Mark
CEPACOL
Category
Trademark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO website

Trademark Timeline

First Use

Jan 1, 2011

Filing Date

Aug 2, 2023

Publication Date

May 21, 2024

Registration Date

Jun 24, 2025

USPTO Records

TitleDateCategorySourcePagesFormatActions

AI AssessmentCached Mar 12, 2026, 11:25 AM
Cached

AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.

Trademark Summary

The standard character mark CEPACOL covers medicated mouthwash in liquid form in International Class 005, with additional domestic classes 006, 018, 044, 046, 051, and 052. It is currently registered on the Principal Register (Registration No. 7846052) as of June 24, 2025, owned by RB Health (US) LLC, a Delaware limited liability company based in Parsippany, New Jersey. This is a divisional child application stemming from Serial No. 98112933, with no active legal proceedings or notable issues.

Recent Activity

Filed on August 2, 2023, the mark faced a non-final office action on March 1, 2024, followed by approval on April 15, 2024, and publication for opposition on May 21, 2024. A statement of use was filed January 7, 2025 (along with a divisional request), accepted June 3, 2025, leading to registration on June 24, 2025.
USPTO
AI Analysis
v2.8.0
Generated Mar 12, 2026, 11:25 AM

Never miss important updates for this trademark

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.